Using augmented reality to assist MRI-guided needle procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot clinical study aims to evaluate the feasibility and safety of an augmented reality needle guidance system during MRI-guided procedures in patients aged 3 to 21. The system, developed under an NIH grant, enhances visualization of the needle's entry point and trajectory, potentially improving accuracy and reducing procedural time. The study will involve up to 12 patients referred for image-guided needle interventions, while maintaining standard care practices. The augmented reality display is designed to assist operators without altering existing procedural techniques.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Male or female, ages 3 to 21
* Patient referred to Interventional Radiology for image-guided needle injection, aspiration, or biopsy.

Exclusion Criteria:

* Patients who are unable to give informed consent themselves or through their parents.
* Patients under 3 years of age
* Patients over 300 pounds.
* Patients who are claustrophobic and unable to tolerate MRI-guided procedure.
* Contraindications to MRI such as MR-unsafe implants.

Where it's running

• Children's National Hospital
  Washington D.C., District of Columbia, United States Recruiting

Study contacts

• Principal investigator: Karun Sharma, MD, PhD — Children's National Research Institute
• Study coordinator: Emily Leibold, BSE
• Email: eleibold@childrensnational.org
• Phone: 202-476-5522

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI analysis of ECGs to detect structural heart disease

  This project will test whether AI can read traditional and wearable ECGs to find undiagnosed valve disease, pulmonary hypertension, and heart failure in adults.

  Recruiting at 6 sites Imperial College London · Bristol and 5 other locations · NCT07057466

• Heart failure with preserved ejection fraction in people with COPD: clinical course and prognosis

  This project will see how often HFpEF appears in people aged 50–70 hospitalized with COPD and whether having HFpEF changes their symptoms, exercise capacity, and prognosis.

  Recruiting at 2 sites National Medical Research Center for Therapy and Preventive Medicine · Kazan' and 1 other locations · NCT07375433

• Botox to improve scar after cleft lip repair

  This study tests whether a Botox injection given during cleft lip repair in infants can lead to better-looking scars in the first year after surgery.

  Recruiting Phase 2 Children's National Research Institute · Washington D.C., District of Columbia · NCT07880860

• Ultra-Rapid Drug Screening Guide for Relapsed Rare Brain Tumors

  This study tests a real-time, tissue-informed drug screening approach to guide personalized treatment for children and young adults with relapsed ultra-rare brain tumors.

  Recruiting Children's National Research Institute · Washington D.C., District of Columbia · NCT07851636

• AI care summaries to help caregivers understand their child’s hospitalization

  This trial tests whether an AI-generated plain-language summary of inpatient notes helps caregivers of hospitalized children understand their child’s care better.

  Recruiting Children's National Research Institute · Washington D.C., District of Columbia · NCT07831018

• Blood-brain barrier opening with focused ultrasound plus T-cell therapy for young DMG patients

  This phase 1 study tests whether opening the blood-brain barrier with focused ultrasound and microbubbles can be safely combined with infusion of tumor-targeted T cells in children and young adults with newly diagnosed diffuse midline glioma.

  Recruiting Phase 1 Children's National Research Institute · Washington D.C., District of Columbia · NCT07796061

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.